Talking Point - Dr Sarah Catchlove & A/Prof Shalini Arunogiri

This presentation will provide an overview of the results of a recently completed open label pilot for individuals experiencing methamphetamine withdrawal. This study investigated the effectiveness of an investigational medication, oxytocin, in improving a range of addiction treatment outcomes, including sleep, during a one-week residential withdrawal admission (detox), as well as the early recovery period.